Physician profile
Ethan Orlev
NPI 1083020564
$1,894.89
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $945 · 2020: $582 · 2021: $136 · 2022: $61.59 · 2023: $146 · 2024: $24.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $170.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $308.59 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $164.96 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $160.48 | 2019-2020 | |
| Pfizer INC. | $151.79 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $145.94 | 2023 | |
| Edwards Lifesciences Corporation | $117.69 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $102.40 | 2019-2020 | |
| Amgen INC. | $86.58 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $82.29 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $79.81 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $73.97 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $52.93 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.42 | 2019-2024 | Jardiance |
| Daiichi Sankyo INC. | $44.83 | 2019-2020 | |
| Abbvie INC. | $44.26 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $36.49 | 2019-2020 | |
| Therapeuticsmd, INC. | $36.26 | 2019 | |
| Nxstage Medical, INC. | $32.69 | 2022 | |
| Astellas Pharma US INC | $25.42 | 2019-2020 | |
| Lilly USA, LLC | $23.75 | 2019 | |
| Aytu Biopharma, INC. | $23.09 | 2019 | |
| Allergan, INC. | $16.55 | 2020 | |
| Sanofi-Aventis U.S. LLC | $11.71 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.12 | 2019 | |
| Sanofi Pasteur INC. | $10.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ethan Orlev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.